[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"body-mass-index\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:body-mass-index":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,56,88,123,151,179,204,236],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":37,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100643083","effectiveness-of-neomayor-in-improving-cardiovascular-health-100643083",false,"NCT07633392","Effectiveness of NeoMayor in Improving Cardiovascular Health","Effectiveness of NeoMayor in Improving Cardiovascular Health Status in Chilean Adults","NEOMAYOR","Inclusion criteria\n\n* Age between 55 and 75 years\n* Able to read and understand written instructions\n* Ownership of a smartphone and ability to use it independently\n* Physically inactive, defined as performing less than 30 minutes of daily physical activity or less than 2,5 h a week).\n* Intermediate or high cardiovascular risk, defined as the presence of at least three of the following: Hypertension (history diagnosed by specialist or general practitioner or ≥ 140 mmHg systolic or ≥90 mm Hg diastolic blood pressure at baseline or current antihypertensive treatment);Diabetes Mellitus (history diagnosed by specialist or general practitioner or fasting blood glucose ≥126 mg\u002FdL or current pharmacologic treatment);Obesity (BMI ≥30 kg\u002Fm²); Dyslipidaemia (history diagnosed by specialist or general practitioner or lipid-lowering drugs or baseline total cholesterol ≥ 200 mg\u002FdL or LDL cholesterol ≥100 mg\u002FdL).\n\nExclusion Criteria\n\n* Dementia defined as a score in the Mini-ACE \\\u003C 21\n* Significant limitations for independent mobility, including use of assistive devices, frailty, gait instability, or lower-limb painful conditions limiting physical activity\n* Uncorrected hearing or visual impairment preventing adequate use of a smartphone\n* Chronic neurological, psychiatric, or psychological disorders without regular treatment or follow-up.\n* Present severe alcohol or illicit drug use.\n* Severe or terminal illness.","ALL","55 Years","75 Years",{"count":21,"type":22},240,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study aims to evaluate the effectiveness of NeoMayor, a mobile health (mHealth) intervention designed to improve cardiovascular health among older adults at elevated cardiovascular risk in Chile. NeoMayor is a smartphone-based application that provides personalized guidance on physical activity, diet, sleep, and mental well-being through a multidomain lifestyle approach.\n\nThis multicenter randomized controlled trial will enroll community-dwelling older adults aged 55 to 75 years recruited from primary healthcare centers in urban and rural settings. Participants will be randomized in a 2:1 ratio to either the NeoMayor intervention or a control group receiving standard health information and usual care. The intervention duration will be four months.\n\nThe primary objective is to determine whether the NeoMayor intervention improves cardiovascular health as measured by the Life's Essential 8 Cardiovascular Health Index. Secondary objectives include evaluating changes in cognitive performance, depressive symptoms, anxiety symptoms, quality of life and physical performance outcomes. The study will also assess feasibility and adherence to digital intervention.",[28,29,30,31,32,33,34,35,36],"Cardiovascular Health Status","Smoking Status","Physical Activity","Diet Quality","Sleep Duration","Body Mass Index","Blood Pressure","LDL Cholesterol","Fasting Glucose",[38,39,40,41,42],"Cardiovascular Health Index","cardiovascular risk","Life's Essential 8","mhealth","older adults","NOT_YET_RECRUITING","2026-06-12",{"date":46,"type":47},"2026-06-16","ACTUAL",{"date":49,"type":22},"2026-09-01",{"date":51,"type":22},"2027-05",{"name":53,"class":54},"University of Chile","OTHER",2,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":4,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":17,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":4,"studyType":23,"phases":67,"briefSummary":68,"conditions":69,"keywords":74,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":55},"100635438","effects-of-high-calorie-diets-vs-high-calorie-formulas-on-weight-gain-in-children-with-congenital-heart-disease--100635438","NCT07552688","\"Effects of High-Calorie Diets VS High-Calorie Formulas on Weight Gain in Children With Congenital Heart Disease \"","\"Effects of High-Calorie Diet vs High-Calorie Formula on Weight Gain and Clinical Outcomes Among Children With Congenital Heart Disease\"","Inclusion Criteria:\n\n* Children aged 1 to 5 years.\n* Diagnosed with congenital heart disease (confirmed by echocardiography).\n* Underweight (weight-for-age below the 10th percentile).\n* Medically stable and eligible for oral or enteral feeding.\n* Informed consent obtained from a parent.\n\nExclusion Criteria:\n\n* Children with genetic syndromes known to affect growth (e.g., Down syndrome).\n* Children with gastrointestinal conditions impairing nutrient absorption.\n* Children who had cardiac surgery within the last 4 weeks.\n* Presence of severe organ failure (renal, hepatic, etc.).\n* Children on parenteral nutrition.\n* Families unlikely to adhere to follow-up or dietary instructions.","1 Year","5 Years",{"count":66,"type":22},75,[25],"This study is a randomized controlled trial designed to evaluate the effects of high-calorie diets and specialized nutritional formulas on weight gain and clinical outcomes in underweight children aged 1 to 5 years with congenital heart disease (CHD). Children with CHD often experience growth failure due to increased energy needs and feeding difficulties, which can negatively impact their recovery, development, and overall health.\n\nSeventy-five children will be randomly assigned to one of three groups: a control group receiving a standard diet, a group receiving a high-calorie diet made from energy-dense foods, and a third group receiving both the high-calorie diet and a specialized high-calorie pediatric formula. The study will measure changes in weight, appetite, feeding tolerance, and other growth indicators over an 8-week period. The goal is to determine whether enhanced nutritional support can improve weight gain and health outcomes in this high-risk population.",[70,33,71,72,73],"Weight Gain","Pediatric Nutrition","Congenital Heart Disease","Undernutrition",[75,76,77,78],"BMI","Nutritional Status","Growth and Development","Pediatric Nursing","2026-04-24",{"date":81,"type":47},"2026-04-29",{"date":83,"type":22},"2026-04-17",{"date":85,"type":22},"2026-06-01",{"name":87,"class":54},"Aryan Najmadin Nasradin",{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":4,"eligibilityCriteria":94,"healthyVolunteers":95,"sex":96,"minAge":97,"maxAge":98,"enrollmentInfo":99,"targetDuration":4,"studyType":101,"phases":4,"briefSummary":102,"conditions":103,"keywords":108,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":122},"100631416","postural-habits-body-awareness-and-functional-performance-across-bmi-categories-in-women-100631416","NCT07500389","Postural Habits, Body Awareness, and Functional Performance Across BMI Categories in Women","Investigation of Postural Habits and Body Awareness in Relation to Functional Performance Across Body Mass Index Categories in Women","Inclusion Criteria:\n\n* Female individuals aged 18-65 years\n* Classified into BMI categories (normal weight, overweight, obesity class I, obesity class II-III)\n* No obesity-related medical or surgical treatment in the last 6 months\n* Able to understand instructions and complete questionnaires\n\nExclusion Criteria:\n\n* Neurological disorders affecting mobility (e.g., stroke, Parkinson's disease, multiple sclerosis, peripheral neuropathy)\n* Rheumatologic or inflammatory diseases (e.g., rheumatoid arthritis, ankylosing spondylitis)\n* Severe orthopedic conditions limiting mobility (e.g., advanced osteoarthritis)\n* Major surgery within the last 12 months affecting mobility or physical performance\n* Pregnancy\n* Acute musculoskeletal injury within the last 4 weeks",true,"FEMALE","18 Years","65 Years",{"count":100,"type":22},80,"OBSERVATIONAL","This cross-sectional study aims to investigate the relationship between postural habits and body awareness with functional performance across different body mass index (BMI) categories in women. Participants will be categorized into four groups based on BMI (normal weight, overweight, obesity class I, and obesity class II-III). Postural habits and awareness, body awareness, and functional performance will be assessed using validated questionnaires and performance-based tests. The study also aims to explore the potential contribution of central adiposity (waist circumference) and psychological factors to these relationships. Findings are expected to provide a more comprehensive understanding of the biomechanical and perceptual factors associated with obesity.",[104,33,105,106,107],"Obesity & Overweight","Postural Control","Body Awareness","Functional Performance",[109,110,111,112],"Postural habits","body awareness","Functional mobility","Physical activity","2026-04-01",{"date":115,"type":47},"2026-04-07",{"date":117,"type":22},"2026-04-30",{"date":119,"type":22},"2026-12-01",{"name":121,"class":54},"Ondokuz Mayıs University",1,{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":4,"eligibilityCriteria":129,"healthyVolunteers":11,"sex":17,"minAge":97,"maxAge":4,"enrollmentInfo":130,"targetDuration":4,"studyType":23,"phases":132,"briefSummary":133,"conditions":134,"keywords":4,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":142,"lastUpdatePostDateStruct":143,"startDateStruct":145,"completionDateStruct":147,"leadSponsor":149,"locationsCount":122},"100484806","a-study-of-the-effect-of-a-nurse-navigator-program-on-high-risk-patients-100484806","NCT05592847","A Study of the Effect of a Nurse Navigator Program on High Risk Patients","The Effect of a Nurse Navigator Program on Readmission Rates for Patients With Elevated BMI, COPD, CHF, Dialysis Use, and H\u002Fo Alcohol Abuse","Inclusion Criteria:\n\n\\- Require total or partial hip or knee replacement and have one or more of the following diagnosis: Heart Failure (HF); Chronic obstructive pulmonary disease (COPD); Dialysis; Alcohol Abuse; Low BMI.\n\nExclusion Criteria:\n\n\\- Decrease cognitive capacity to consent to the study.",{"count":131,"type":22},300,[25],"The purpose of this study is to examine if educational intervention in high risk patients can lead to decreased hospital readmissions when compared to patients who are not in the intervention program. Additionally, to determine patient satisfaction with the educational program.",[135,136,137,138,139,140,33,141],"Patient Readmission","Arthroplasty, Replacement, Knee","Arthroplasty, Replacement, Hip","Heart Failure","Pulmonary Disease, Chronic Obstructive","Renal Insufficiency","Alcoholism","2026-03-17",{"date":144,"type":47},"2026-03-19",{"date":146,"type":22},"2027-01",{"date":148,"type":22},"2027-06",{"name":150,"class":54},"Mayo Clinic",{"id":152,"slug":153,"hasResults":11,"nctId":154,"briefTitle":155,"officialTitle":155,"acronym":4,"eligibilityCriteria":156,"healthyVolunteers":11,"sex":17,"minAge":97,"maxAge":98,"enrollmentInfo":157,"targetDuration":4,"studyType":101,"phases":4,"briefSummary":159,"conditions":160,"keywords":164,"overallStatus":169,"whyStopped":4,"lastUpdateSubmitDate":170,"lastUpdatePostDateStruct":171,"startDateStruct":173,"completionDateStruct":175,"leadSponsor":177,"locationsCount":122},"100604668","the-effect-of-body-weight-on-physical-activity-level-functional-capacity-balance-and-quality-of-life-in-individuals-with-type-2-diabetes-mellitus-100604668","NCT07152509","The Effect of Body Weight on Physical Activity Level, Functional Capacity, Balance, and Quality of Life in Individuals With Type 2 Diabetes Mellitus","Inclusion Criteria:\n\n* Having a diagnosis of Type 2 Diabetes Mellitus for at least 1 year\n* Being between 18 and 65 years of age\n* Having an HbA1c value between 6.5% and 11% at the time of diagnosis\n* No cognitive or mental problems\n* Ability to walk independently\n* Willingness to participate in the study\n\nExclusion Criteria:\n\n* Presence of uncontrolled cardiovascular and pulmonary disease\n* Presence of vertigo or various vestibular system disorders\n* Presence of severe neurological or respiratory disease\n* History of stroke or myocardial infarction\n* Presence of a major musculoskeletal problem\n* Presence of chronic renal failure\n* Presence of diabetic ulcer or neuropathy\n* Pregnancy\n* Presence of hemolytic or renal anemia\n* Presence of serious visual, hearing, or speech impairments leading to lack of cooperation",{"count":158,"type":22},50,"This study aims to investigate the effects of body weight on physical activity level, functional capacity, balance, and quality of life in patients with type 2 diabetes mellitus (T2DM). A total of 50 volunteer patients who meet the inclusion criteria will be recruited from the Internal Medicine and Nutrition outpatient clinics of Bezmialem Vakıf University Hospital.\n\nParticipants will be prospectively evaluated through face-to-face interviews. Assessments will include body composition analysis (Omron Body Composition Monitor), waist-to-hip ratio, lower extremity muscle strength (Muscle Hand-Held Dynamometer), grip strength (Hand Grip Dynamometer), physical activity level (International Physical Activity Questionnaire-Short Form), functional capacity (6-Minute Walk Test), balance (Biodex Balance System), clinical balance (Berg Balance Scale), and quality of life (Nottingham Health Profile).\n\nAll statistical analyses will be performed using IBM SPSS Statistics 20. With this study, we aim to comprehensively evaluate multiple parameters in individuals with T2DM and investigate their interrelationships, thereby contributing to the current body of knowledge in the literature.",[161,33,162,163],"Type 2 Diabetes Mellitus (T2DM)","Functional Capacity","Balance",[165,166,167,168],"quality of life","type 2 diabetes mellitus","body mass index","physical activity","RECRUITING","2025-08-26",{"date":172,"type":47},"2025-09-03",{"date":174,"type":47},"2025-08-15",{"date":176,"type":22},"2025-10-15",{"name":178,"class":54},"Bezmialem Vakif University",{"id":180,"slug":181,"hasResults":11,"nctId":182,"briefTitle":183,"officialTitle":184,"acronym":4,"eligibilityCriteria":185,"healthyVolunteers":11,"sex":17,"minAge":97,"maxAge":186,"enrollmentInfo":187,"targetDuration":189,"studyType":101,"phases":4,"briefSummary":190,"conditions":191,"keywords":4,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":122},"100602158","the-role-of-oxygen-reserve-index-ori-in-apneic-ventilation-100602158","NCT07119866","The Role of Oxygen Reserve Index (ORi) in Apneic Ventilation","The Role of Oxygen Reserve Index (ORi) Monitoring in Optimizing Apneic Ventilation for Laparoscopic Cholecystectomy","Inclusion Criteria:\n\n* 18-60 years\n* ASA 1-2\n* Mallampati score \\\u003C2\n* Scheduled for elective laparoscopic cholecystectomy under general anesthesia\n\nExclusion Criteria:\n\n* \\\u003C18 and \\>60 years\n* ASA 3-4\n* Initial ORI value below 0.24","60 Years",{"count":188,"type":22},60,"1 Day","Background: The Oxygen Reserve Index (ORI) is a non-invasive parameter utilizing multi-wavelength pulse co-oximetry. ORI can provide early warnings of deteriorating oxygenation before changes are reflected in SpO₂ levels. This study aimed to investigate the feasibility of non-ventilated intubation in patients undergoing cholecystectomy as a means to achieve safe intubation without nasogastric tube placement, with reduced trauma and cost, and improved time efficiency.",[192,193,194,33],"Oxygen Reserve Index","Apnea","Ventilation","2025-08-06",{"date":197,"type":47},"2025-08-13",{"date":199,"type":22},"2025-08-07",{"date":201,"type":22},"2025-08-30",{"name":203,"class":54},"Ankara City Hospital Bilkent",{"id":205,"slug":206,"hasResults":11,"nctId":207,"briefTitle":208,"officialTitle":208,"acronym":209,"eligibilityCriteria":210,"healthyVolunteers":95,"sex":17,"minAge":211,"maxAge":212,"enrollmentInfo":213,"targetDuration":4,"studyType":101,"phases":4,"briefSummary":215,"conditions":216,"keywords":221,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":227,"lastUpdatePostDateStruct":228,"startDateStruct":230,"completionDateStruct":232,"leadSponsor":234,"locationsCount":122},"100575957","clinical-profile-of-skin-aging-based-on-dermoscopy-photoaging-scale-and-glogau-scale---study-of-leucocyte-telomere-length-biomarker-p16-and-body-mass-index-100575957","NCT06779032","Clinical Profile of Skin Aging Based on Dermoscopy Photoaging Scale and Glogau Scale - Study of Leucocyte Telomere Length, Biomarker P16, and Body Mass Index","LTLP16","Inclusion Criteria:\n\n* female aged 31-61 years\n* healthy\n* willing to participate in the study\n\nExclusion Criteria:\n\n* history of diseases (heart, kidney, liver)\n* pregnant or breastfeeding patientes","31 Years","61 Years",{"count":214,"type":22},70,"To determine the relationship between clinical appearance, dermoscopic examination results of photoaging profiles based on clinical examination, DPAS score and leucocyte telomere length, to analyze the relationship between BMI, waist circumference, triglycerides, and cellular senescence biomarker p16 levels with a population experiencing skin aging and having Fitzpatrick III-V skin types.\n\nThe questions which is aim to be answered are:\n\n1. What is the photoaging profile based on clinical examination results in skin aging cases?\n2. What is the photoaging profile based on DPAS scores in skin aging cases?\n3. What is the leucocyte telomere length profile in skin aging cases?\n4. What is the relationship between leucocyte telomere length and clinical examination in skin aging cases?\n5. What is the relationship between leucocyte telomere length and DPAS degree in skin aging cases?\n6. What is the profile of cellular senescence p16 biomarker levels in a population that has experienced clinical skin aging with Fitzpatrick III-V skin types?\n7. What is the skin aging profile based on the Glogau and DPAS scales in a population with Fitzpatrick III-V skin types?\n8. Is there a relationship between the results of the cellular senescence p16 biomarker examination and clinical skin aging assessed based on the Glogau and DPAS scales in a population with Fitzpatrick III-V skin types?\n9. Is there a relationship between the results of BMI, waist circumference, and triglyceride examinations with clinical skin aging assessed using the Glogau and DPAS scales with Fitzpatrick III-V skin types?",[217,33,218,219,220],"Aging Skin","Cellular Senescence","Triglycerides","Waist Circumference",[222,167,223,224,225,226],"skin aging","triglycerides","waist circumference","cellular senescene","p16","2025-01-12",{"date":229,"type":47},"2025-01-16",{"date":231,"type":22},"2025-02-05",{"date":233,"type":22},"2025-08-20",{"name":235,"class":54},"Indonesia University",{"id":237,"slug":238,"hasResults":11,"nctId":239,"briefTitle":240,"officialTitle":241,"acronym":4,"eligibilityCriteria":242,"healthyVolunteers":95,"sex":17,"minAge":97,"maxAge":98,"enrollmentInfo":243,"targetDuration":4,"studyType":101,"phases":4,"briefSummary":245,"conditions":246,"keywords":4,"overallStatus":169,"whyStopped":4,"lastUpdateSubmitDate":249,"lastUpdatePostDateStruct":250,"startDateStruct":252,"completionDateStruct":254,"leadSponsor":256,"locationsCount":122},"100573363","activities-of-daily-living-and-upper-extremity-exercise-capacity-of-individuals-with-high-body-mass-index-100573363","NCT06745310","Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index","Comparison of Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index with Those with Normal Body Mass Index","Inclusion Criteria for individuals with high body mass index:\n\n* Body mass index ≥ 25 kg\u002Fm2\n* Volunteering for the study\n\nExclusion Criteria for individuals with high body mass index:\n\n* Having uncontrolled hypertension, diabetes mellitus\n* Having comorbidities that may affect physical functions\n* Failure to cooperate with tests to be performed\n* Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases\n* Pregnancy\n* Having a history of bariatric surgery\n* Presence of contraindications to exercise testing\n\nInclusion Criteria for individuals with normal body mass index:\n\n* Body mass index 18.5-24.9 kg\u002Fm2\n* Volunteering for the study\n\nExclusion Criteria for individuals with normal body mass index:\n\n* Body mass index \\> 25 kg\u002Fm2 or ≤18.5 kg\u002Fm2\n* Having a known chronic or systemic disease\n* Failure to cooperate with tests to be performed",{"count":244,"type":22},24,"Individuals with high and normal body mass index will be included in this study.",[33,247,248],"Body Mass Index 25 or Greater","Body Mass Index, Normal","2024-12-17",{"date":251,"type":47},"2024-12-20",{"date":253,"type":47},"2024-12-12",{"date":255,"type":22},"2025-12",{"name":257,"class":54},"Kirsehir Ahi Evran Universitesi"]